Latest News
Feature
Medicaid’s share of state budgets continues to grow
States provided $574 billion in benefits during fiscal 2017.
Feature
After 6 weeks, HealthCare.gov activity still ahead of last year
As the end of this year’s open enrollment nears, however, plan selections are only about half of last year’s total.
Conference Coverage
VIDEO - New lymphoma drug approvals: Clinical use, future directions
ATLANTA - At the ASH annual meeting, FDA representatives and clinicians discussed new lymphoma drug approvals and their use in the real-world...
Conference Coverage
VIDEO: Joint FDA-ASH session highlights new AML drugs
ATLANTA – During a special interest session at the ASH annual meeting, FDA representatives and clinicians discussed new drugs available for the...
Conference Coverage
Clinic eases pediatric-adult transition in sickle cell disease
CONCORD, N.C. – Transitional programs could help teenage patients continue self-care and avoid risk behaviors.
Conference Coverage
VIDEO: SABCS 2017 roundtable with Dr. Hope S. Rugo and Dr. William J. Gradishar
SAN ANTONIO – Dr. Hope S. Rugo and Dr. William J. Gradishar share their reflections on duration of therapy, ovarian suppression, immunotherapy,...
Conference Coverage
VIDEO: Ibrutinib PFS is nearly 3 years in MCL patients who had one prior therapy
ATLANTA – Dr. Simon Rule discusses the implications of the study and how ibrutinib stacks up against other therapies for MCL.
Conference Coverage
VIDEO: Caplacizumab sped platelet response, improved clinical outcomes in acquired TTP
ATLANTA – Phase 2 data on aTTP earned caplacizumab an FDA fast track designation in July 2017.
Conference Coverage
Denmark reinstates ID NAT screening for blood donations
SAN DIEGO – “The Danish government decided not to discontinue NAT because there were almost no savings.”
Conference Coverage
VTE rates in lenalidomide-treated NHL may warrant prophylaxis
ATLANTA – Lenalidomide as single agent had twice the VTE rate as lenalidomide with a biologic.
Conference Coverage
CDK4/6 inhibitors have similar efficacy in older breast cancer patients
SAN ANTONIO – Treatment with CDK4/6 inhibitors appears to have the same efficacy in older breast cancer patients, as compared with younger ones....